Skip to main content
SpringerLink
Log in

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures

  • Original Articles
  • LAK Cells, Long-term Culture, CD Marker Cytotoxicity, Cytokines
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

A series of 62 lymphokine-activated killer cell (LAK) cultures from 44 different donors was investigated for the distribution of various CD markers during a cultivation period of 3 weeks. Great differences in the phenotypic pattern were found between different donors, but similar changes of the subset pattern of various donors allowed a classification of the LAK cultures into four distinct LAK types. LAK type 1 was characterised by low numbers of CD3+ cells and high values for CD56+ cells. In LAK type 2 cultures γ/δTCR+ cells extensively proliferated, whereas in LAK type 3 cultures the CD57 and CD8 values increased considerably. LAK type 4 cultures did not show any of these characteristics. The resulting phenotype of a LAK culture was donor-specific, as LAK cultures established from the same peripheral blood mononuclear cells (PBMC), fresh or after cryopreservation, or from PBMC obtained from the same donor at different venous punctures, always developed the same phenotype. A clear correlation between phenotype and killing activity could only be found for LAK type 1 cultures, which always developed high lytic activity. Long-term IL-2 stimulation induced high levels of perforin-positive cells in LAK cultures but the perforin content did not correlate with the cytotoxicity. The transcription pattern for various cytokines only varied slightly between the cultures. Messenger RNA for granulocyte/macrophage-colony-stimulating factor, interferon γ, tumour necrosis factor α, interleukin-4 (IL-4) and IL-5 were found in almost all cultures during the entire cultivation period, whereas mRNA for IL-2 was never detected. Most variations in the transcription pattern were observed for IL-6 and IL-7. However, no correlation could be found between the endogenous cytokine production and the phenotype or lytic activity of the LAK cultures. Further studies are required to determine the factors that cause lymphocyte subsets from a specific donor to proliferate preferentially under long-term IL-2 stimulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Autran B, Leblond V, Sadat-Sowti B, Lefranc E, Got P, Sutton L, Binet JL, Debré P (1991) A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77: 2237

    PubMed  Google Scholar 

  2. Bergmann L, Weidmann E, Bungert B, Hechler P, Mitrou PS (1990) Influence of various cytokines on the induction of lymphokine-activated killer cells. Nat Immum Cell Growth Regul 9: 265

    Google Scholar 

  3. Crump WL, Owen-Schaub LB, Grimm EA (1989) Human recombinant interleukin-1 is synergistic with interleukin-2 in the generation of lymphokine-activated killer cells. Cancer Res 49: 149

    PubMed  Google Scholar 

  4. Damle NK, Doyle LV, Bradley EC (1986) Interleukin 2-activated human killer cells are derived from phenotypically hetergeneous precursors. J Immunol 137: 2814

    PubMed  Google Scholar 

  5. Ebina N, Gallardo D, Shau H, Golub SH (1990) IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity. Br J Cancer 62: 619

    PubMed  Google Scholar 

  6. Farace F, Pallardy M, Angevin E, Hercend T, Escudier B, Triebel F (1994) Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon γ: immunological monitoring. Int J Cancer 57: 814

    PubMed  Google Scholar 

  7. Findley HW, Nasr S, Afify Z, Hnath R, Waldrep K, Ragab AH (1990) Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro. Cancer Invest 8: 493

    PubMed  Google Scholar 

  8. Fisch P, Malkovsky M, Braakman E, Sturm E, Bolhuis RLH, Prieve A, Sosman JA, Lam VA, Sondel PM (1990) γ/δ T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med 171: 1567

    PubMed  Google Scholar 

  9. Fuchshuber PR, Lotzova E, Pollock RE (1991) Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes. Lymphokine Cytokine Res 10: 51

    PubMed  Google Scholar 

  10. Gallagher G, Stimson WH, Findlay J, Al-Azzawi F (1990) Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother 31: 49

    PubMed  Google Scholar 

  11. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine activated killer cell phenomenon. Lysis of natural killer cell resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823

    PubMed  Google Scholar 

  12. Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA (1983) Lymphokine activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med 157: 884

    PubMed  Google Scholar 

  13. Hameed A, Gohlsen KJ, Cheng L, Fox WM, Hruban RH, Podack ER (1992) Immunhistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 140: 1025

    PubMed  Google Scholar 

  14. Herberman RB, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R, Golub S, Lanier LL, Phillips JH, Riccardi C, Ritz J, Santoni A, Schmidt RE, Uchida A (1987) Lymphokine-activated killer cell activity. Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today 8: 178

    Google Scholar 

  15. Kaur I, Voss SD, Gupta RS, Schell K, Fisch P, Sondel PM (1993) Human peripheral γδ T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells. J Immunol 150: 2046

    PubMed  Google Scholar 

  16. Kjeldsen-Kragh J, Quayle AJ, Skalhegg BS, Sioud M, Forre O (1993) Selective activation of resting human γδ T lymphocytes by interleukin-2. Eur J Immunol 23: 2092

    PubMed  Google Scholar 

  17. Koberda J, Bergmann L, Mitrou PS, Hoelzer D (1991) High release of tumor necrosis factor α, interferon γ and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells. J Cancer Res Clin Oncol 117: 425

    PubMed  Google Scholar 

  18. Kovacs EJ, Beckner SK, Longo DL, Varesio L, Young HA (1989) Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1β by interleukin 2. Cancer Res 49: 940

    PubMed  Google Scholar 

  19. Krähenbühl O, Tschopp J (1991) Perforin-induced pore formation. Immunol Today 12: 399

    PubMed  Google Scholar 

  20. Limb GA, Meager A, Woolley J, Wadhwa M, Biggerstaff J, Brown KA (1989) Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. Immunology 68: 514

    PubMed  Google Scholar 

  21. Mehta S, Flanagan P, Blackinton D, Wanebo H (1992) Lymphokine-activated effector cells: modulation of activity by cytokines. Lymphokine Cytokine Res 11: 73

    PubMed  Google Scholar 

  22. Moser R, Groscurth P, Fehr J (1990) Promotion of transendothelial neutrophil passage by human thrombin. J Cell Sci 96: 737

    PubMed  Google Scholar 

  23. Owen-Schaub LB, Gutterman JU, Grimm EA (1988) Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor α and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res 48: 788

    PubMed  Google Scholar 

  24. Quan CP, Watanabe S, Vuillier F, Pires R, Matsuo T, Stanislawski M, Pillot J, Bouvet JP (1993) Purification and partial amino acid sequence of suppressive lymphokine from a CD8+CD57+ human T hybridoma. Immunology 78: 205

    PubMed  Google Scholar 

  25. Roussel E, Gerrard JM, Greenberg AH (1990) Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+CD16−CD56− large granular lymphocyte LAK cells. Clin Exp Immunol 82: 416

    PubMed  Google Scholar 

  26. Sadat-Sowti B, Debré P, Idziorek T, Guillon JM, Hadida F, Okzenhendler E, Katlama C, Mayaud C, Autran B (1991) A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol 21: 737

    PubMed  Google Scholar 

  27. Saraya KA, Balkwill FR (1993) Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression. Br J Cancer 67: 514

    PubMed  Google Scholar 

  28. Singh SM, Sone S, Inamura N, Ogura T (1989) Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes. Int J Cancer 44: 170

    PubMed  Google Scholar 

  29. Spagnoli GC, Juretic A, Schultz-Thater E, Dellabona P, Filgueira L, Hörig H, Zuber M, Garotta G, Heberer M (1993) On the relative role of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Cell Immunol 146: 391

    PubMed  Google Scholar 

  30. Sturm E, Braakman E, Fisch P, Vreugdenhil RJ, Sondel P, Bolhius RLH (1990) Human Vγ2 T cell receptor-γδ lymphocytes show specificity to Daudi Burkitt's lymphoma cells. J Immunol 145: 3202

    PubMed  Google Scholar 

  31. Testa U, Care A, Montesoro E, Fossati C, Giannella G, Masciulli R, Fagioli M, Bulgarini D, Habetswallner D, Isacchi G, Pelicci PG, Peschle C (1990) Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokineactivated killer cells with natural killer, Tiγ/δ or TNK phenotype. Cancer Immunol Immunother 31: 11

    PubMed  Google Scholar 

  32. Vollenweider I, Vrbka E, Fierz W, Groscurth P (1993) Heterogeneous binding and killing behaviour of human γ/δTCR+ lymphokine-activated killer cells against K562 and Daudi cells. Cancer Immunol Immunother 36: 331

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Anatomy, Division of Cell Biology, University of Zürich-Irchel, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland

    Iren Vollenweider & Peter Groscurth

  2. Department of Medicine, Division of Haematology, University Hospital, CH-8091, Zürich, Switzerland

    René Moser

Authors
  1. Iren Vollenweider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. René Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Groscurth
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by the Sasselia Foundation, Zürich

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vollenweider, I., Moser, R. & Groscurth, P. Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures. Cancer Immunol Immunother 39, 305–312 (1994). https://doi.org/10.1007/BF01519983

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01519983

Key words

Search

Navigation